Skip to main content

News

NEW SINGLE CAPSULE TREATMENT AKYNZEO™ NOW AVAILABLE FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN CANADA

Published on November 28, 2017

Pickering, ON (Canada) (November 28, 2017): Purdue Pharma (Canada) announce today that AKYNZEO™ (netupitant/palonosetron hydrochloride)…

Read More

David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada)

Published on September 25, 2017

Pickering, Ontario, September 25, 2017/CNW/ — David A. Pidduck has been appointed as President and…

Read More

Purdue Pharma (Canada) appoints Dr. Tom Koutsavlis as new Vice President, Research and Development

Published on July 5, 2017

PICKERING, ON, July 5, 2017 /CNW/ – Dr. Tom Koutsavlis, MD, MSc, FRCPC, MBA, has…

Read More

Dr. Craig Landau Appointed President and CEO Purdue Pharma L.P.

Published on June 22, 2017

Dr. Craig Landau Appointed President and CEO Purdue Pharma LP. Read the Press Release issued…

Read More

ARCHIVE

2017
2016
2015
2014
2013
2012

SETTING THE RECORD STRAIGHT

The Impact of Pain

For all media inquiries, please contact:

media@purdue.ca

↓